Breakthrough Drug Extends Pancreatic Cancer Survival | Lansing News

Pancreatic cancer just got a major breakthrough: an experimental drug called Daraxon-Rasib is showing patients living twice as long compared to standard chemo, targeting the K-Ras mutation present in 90% of cases — a long-elusive cancer driver. Scientists call this the first significant advance in decades, offering real hope for a disease often caught too late. Trials are ongoing, but early results are incredibly promising. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/da8f961d7784d17a